OrbiMed Doubles Down on RNA Therapies
19 Oct 2023
US$ 19.00
OrbiMed Advisor LLC and Creacion Ventures have made a follow-on investment in the US$60 million series B funding round...
Related Publications
A consortium which consists of Abu Dhabi Investment Authority (ADIA), Global Infrastructure Partners, Khazanah Nasional...
KKR & Co Inc (KKR) announced its intention to launch its second tranche of tender offer (TOB) for shares of FUJI SOFT...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.